Dupont Capital Management Corp Abb Vie Inc. Transaction History

Dupont Capital Management Corp

$1.18 Billion
Q3 2024

A detailed history of Dupont Capital Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Dupont Capital Management Corp holds 62,092 shares of ABBV stock, worth $12.5 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

62,092

Previous 62,092 -0.0%

Holding current value

$12.5 Million

Previous $10.7 Million 15.13%

% of portfolio

1.04%

Previous 0.94%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$154.79 - $180.76 $9.61 Million - $11.2 Million	62,092 New	62,092 $10.7 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $232,687 - $289,564	-1,756 Reduced 15.82%	9,346 $1.26 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $588,851 - $678,150	-4,072 Reduced 26.84%	11,102 $1.77 Million
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $1.64 Million - $1.96 Million	-11,840 Reduced 43.83%	15,174 $0
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $3.02 Million - $3.46 Million	-22,481 Reduced 45.42%	27,014 $3.63 Million
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $1.66 Million - $2.11 Million	12,037 Added 32.13%	49,495 $7.58 Million
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $1.44 Million - $1.79 Million	10,916 Added 41.13%	37,458 $6.07 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $1.79 Million - $2.27 Million	-16,692 Reduced 38.61%	26,542 $3.59 Million
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $1.25 Million - $1.42 Million	-11,722 Reduced 21.33%	43,234 $4.66 Million
Q2 2021 Jul 30, 2021	SELL	$105.21 - $117.21 $169,703 - $189,059	-1,613 Reduced 2.85%	54,956 $6.19 Million
Q1 2021 Apr 29, 2021	SELL	$102.3 - $112.62 $745,664 - $820,887	-7,289 Reduced 11.41%	56,569 $6.12 Million
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $245,333 - $331,226	-3,048 Reduced 4.56%	63,858 $6.84 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $483,157 - $567,067	-5,624 Reduced 7.75%	66,906 $5.86 Million
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $1.13 Million - $1.52 Million	15,434 Added 27.03%	72,530 $7.12 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $517,096 - $783,982	8,017 Added 16.33%	57,096 $4.35 Million
Q4 2019 Jan 27, 2020	SELL	$72.13 - $90.25 $133,368 - $166,872	-1,849 Reduced 3.63%	49,079 $4.35 Million
Q3 2019 Oct 28, 2019	BUY	$62.98 - $75.72 $231,829 - $278,725	3,681 Added 7.79%	50,928 $3.86 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $387,630 - $495,482	-5,900 Reduced 11.1%	47,247 $3.44 Million
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $2.79 Million - $3.28 Million	-36,166 Reduced 40.49%	53,147 $4.28 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $1.59 Million - $1.96 Million	-20,452 Reduced 18.63%	89,313 $8.23 Million
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $887,499 - $986,620	-9,982 Reduced 8.34%	109,765 $10.4 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $1.48 Million - $1.75 Million	-16,490 Reduced 12.1%	119,747 $11.1 Million
Q1 2018 May 02, 2018	BUY	$92.01 - $123.21 $4.12 Million - $5.52 Million	44,828 Added 49.04%	136,237 $12.9 Million
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $59,199 - $64,916	661 Added 0.73%	91,409 $8.84 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $6.34 Million - $8.1 Million	90,748	90,748 $8.06 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account

Dupont Capital Management Corp Abb Vie Inc. Transaction History